|
CLIP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.822400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.236700E-04 |
| Normal-vs-Stage2 |
3.825000E-01 |
| Normal-vs-Stage3 |
4.273600E-02 |
| Normal-vs-Stage4 |
7.580000E-01 |
| Stage1-vs-Stage2 |
3.933800E-01 |
| Stage1-vs-Stage3 |
6.198200E-01 |
| Stage1-vs-Stage4 |
1.125880E-02 |
| Stage2-vs-Stage3 |
6.280800E-01 |
| Stage2-vs-Stage4 |
5.430200E-01 |
| Stage3-vs-Stage4 |
1.641990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.619600E-03 |
| Normal-vs-AfricanAmerican |
9.396700E-03 |
| Normal-vs-Asian |
6.561200E-01 |
| Caucasian-vs-AfricanAmerican |
7.117200E-01 |
| Caucasian-vs-Asian |
2.454000E-01 |
| AfricanAmerican-vs-Asian |
2.933400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.965760E-02 |
| Normal-vs-Female |
8.159900E-04 |
| Male-vs-Female |
2.760800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.467200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.201800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.844100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.557720E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.865200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.418600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.357200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.287200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.436000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.792800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.338360E-02 |
| Normal-vs-Grade 2 |
9.603000E-03 |
| Normal-vs-Grade 3 |
2.030600E-04 |
| Normal-vs-Grade 4 |
7.675200E-01 |
| Grade 1-vs-Grade 2 |
3.396000E-01 |
| Grade 1-vs-Grade 3 |
5.510200E-01 |
| Grade 1-vs-Grade 4 |
3.845700E-02 |
| Grade 2-vs-Grade 3 |
5.231600E-01 |
| Grade 2-vs-Grade 4 |
1.336610E-01 |
| Grade 3-vs-Grade 4 |
3.181900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.27459999957836E-07 |
| Normal-vs-ccB subtype |
9.606800E-01 |
| ccA subtype-vs-ccB subtype |
1.215880E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.746350E-02 |
| Normal-vs-N1 |
5.119400E-01 |
| N0-vs-N1 |
1.024760E-01 |
|
|
